Although COVID‐19 was first found to target to the respiratory system, growing evidence highlights the wide distribution of ACE2 enables SARS-CoV-2 to cause a systemic disease characterized by multiple organ involvement [28, 29]. This evidence concerns the gene ACE2 and COVID-19.